Telios Pharmaceuticals
Executive Summary
Wound-healing R&D company recruits former Lilly executive Donald Grimm as president and CEO, effective June 15. Grimm, 52, spent 22 years at Lilly in sales, marketing and general management positions; most recently he served as president and CEO of Lilly's Hybritech biotech subsidiary...